DOI: 10.5176/2251-2039_IE1221
Authors: Hossein Askari and Richard C. Geibel
Abstract: The paper presented discusses aspects of the “Opportunity Recognition” (OR) in the medical biotechnology (MBT) and aims to determine parameters which are important for the recognition of opportunities and find out to what degree start-ups in the MBT field differ from other sectors.
